Article info

Download PDFPDF

5PSQ-076 Efficacy and safety of nivolumab monotherapy vs nivolumab plus ipilimumab in renal cell carcinoma in clinical practice
Free

Authors

Citation

Zambrano Croche M, Rojas Albarrán A, García ÁG, et al
5PSQ-076 Efficacy and safety of nivolumab monotherapy vs nivolumab plus ipilimumab in renal cell carcinoma in clinical practice

Publication history

  • First published March 20, 2024.
Online issue publication 
March 20, 2024

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.